GLP-1 drug users drive supplement sales as doctors and regulators raise concerns over marketing and oversight. Read more at ...

By Nicholas P. Brown NEW YORK, Oct 20 (Reuters) - For Allison Vecchio, 42, GLP-1 drugs were "a reset button on life," but at ...

Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical readouts.

Turmeric is a popular spice with antioxidant properties. Foods and supplements to avoid mixing with turmeric include iron, ...

GLP-1s are very effective at managing diabetes, obesity and weight-related conditions. But they can come with side effects, ...

An unexpected shot of bad news. A popular weight-loss shot has been recalled across the country by the FDA due to potential ...

Scientists have discovered that many common sweeteners can interfere with gut bacteria, with some combinations involving ...

The October 21st edition of "AI BUSINESS HUNTER" continues our established policy of prioritizing potential to transform ...

I rate Personalis a Sell at the current share price of $16.57, as the stock already trades above the $16.25 acquisition consideration. I expect the transaction to close but see limited upside for PSNL ...

Rising supplement use among GLP-1 patients boosts sales as doctors and regulators question product safety, marketing claims ...

Astronomers analyzed 2,435 galaxies hosting actively feeding black holes using data from the Dark Energy Spectroscopic Instrument (DESI). Among them, they identified 546 "bulgeless" galaxies—systems ...

Issa Rae received the Entertainment Entrepreneur of the Year Award at Variety's L.A. Power of Women event on Wednesday in Beverly Hills. The award was presented by U.S. Bank senior executive vice ...